SV2A
- 29 trials
- Funder: National Institute on Aging
- 29 of 29 trials sponsored by developers of drugs on it
- Humans1
Funding
2 grants since 2025National Institute on AgingUS$627.2k
Latest
1 in 12 monthsNeuropsychopharmacology
Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [¹¹C]UCB-J positron emission tomography study
Cohort study in peopleSynapse